These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 34960792)
1. Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein-Barr Virus in Classical Hodgkin Lymphoma. Santisteban-Espejo A; Perez-Requena J; Atienza-Cuevas L; Moran-Sanchez J; Fernandez-Valle MDC; Bernal-Florindo I; Romero-Garcia R; Garcia-Rojo M Viruses; 2021 Dec; 13(12):. PubMed ID: 34960792 [TBL] [Abstract][Full Text] [Related]
2. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly. Wang E; Papavassiliou P; Sebastian S Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus infection is inversely correlated with the expression of retinoblastoma protein in Reed-Sternberg cells in classic Hodgkin lymphoma. Al-Salam S; Awwad A; Alashari M Int J Clin Exp Pathol; 2014; 7(11):7508-17. PubMed ID: 25550786 [TBL] [Abstract][Full Text] [Related]
4. Impact of Epstein-Barr virus in the clinical evolution of patients with classical Hodgkin's lymphoma in Brazil. Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Assis MG; Eiras DP; Dobo C; Oliveira JS Hematol Oncol; 2010 Sep; 28(3):137-41. PubMed ID: 20128016 [TBL] [Abstract][Full Text] [Related]
5. Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma. Park JH; Yoon DH; Kim S; Park JS; Park CS; Sung H; Lee SW; Huh J; Suh C Ann Hematol; 2016 Apr; 95(5):801-8. PubMed ID: 26883027 [TBL] [Abstract][Full Text] [Related]
6. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion. Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478 [TBL] [Abstract][Full Text] [Related]
7. [Clinical features and prognosis of CD20-positive classical Hodgkin lymphoma]. Qin Y; Kang SY; He XH; Zhou SY; Liu P; Yang JL; Zhang CG; Yang S; Gui L; Shi YK Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2224-8. PubMed ID: 27480653 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy. Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055 [TBL] [Abstract][Full Text] [Related]
9. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice. Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010 [TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Chetaille B; Bertucci F; Finetti P; Esterni B; Stamatoullas A; Picquenot JM; Copin MC; Morschhauser F; Casasnovas O; Petrella T; Molina T; Vekhoff A; Feugier P; Bouabdallah R; Birnbaum D; Olive D; Xerri L Blood; 2009 Mar; 113(12):2765-3775. PubMed ID: 19096012 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study. Elsayed AA; Asano N; Ohshima K; Izutsu K; Kinoshita T; Nakamura S Pathol Int; 2014 Jul; 64(7):336-45. PubMed ID: 25047504 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma. Jimenez O; Colli S; Garcia Lombardi M; Preciado MV; De Matteo E; Chabay P Cancer Immunol Immunother; 2021 Jun; 70(6):1519-1526. PubMed ID: 33184699 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study. Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM; Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326 [TBL] [Abstract][Full Text] [Related]
14. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases. Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994 [TBL] [Abstract][Full Text] [Related]
15. Pediatric Hodgkin lymphoma in a South Indian regional cancer center: its immunomorphology, tumor-associated macrophages, and association with Epstein-Barr virus. Zameer MA; Premalata CS; Arunakumari B; Appaji L; Rao CR Pediatr Hematol Oncol; 2015 May; 32(4):229-38. PubMed ID: 25252151 [TBL] [Abstract][Full Text] [Related]
16. Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells. Pavlovic A; Glavina Durdov M; Capkun V; Jakelic Pitesa J; Bozic Sakic M Med Sci Monit; 2016 Jul; 22():2340-6. PubMed ID: 27377121 [TBL] [Abstract][Full Text] [Related]
17. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. Herling M; Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH Clin Cancer Res; 2003 Jun; 9(6):2114-20. PubMed ID: 12796376 [TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment and RIG-I signaling molecules in Epstein Barr virus-positive and -negative classical Hodgkin lymphoma of the elderly. Satoh T; Wada R; Yajima N; Imaizumi T; Yagihashi S J Clin Exp Hematop; 2014; 54(1):75-84. PubMed ID: 24942949 [TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma. Li PC; Siddiqi IN; Mottok A; Loo EY; Wu CH; Cozen W; Steidl C; Shih JC J Pathol; 2017 Oct; 243(2):220-229. PubMed ID: 28722111 [TBL] [Abstract][Full Text] [Related]
20. A fulminant case of classical Hodgkin lymphoma: A diagnostic dilemma of Epstein-Barr virus-positive large B-cell neoplasms. Ichimata S; Kobayashi M; Ohya M; Otsuki T; Yanagisawa K; Tateishi K; Kato A; Matsuo A; Kanno H Pathol Int; 2019 Jul; 69(7):407-413. PubMed ID: 31215109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]